Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
HTECvsFBTETF Comparison
Robo Global Healthcare Technology and Innovation ETF
Robo Global Healthcare Technology and Innovation ETF (HTEC) belongs to the Multiple Trends segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. HTEC's top 3 sector exposures are Health Care, Consumer Discretionary and Information Technology. In contrast, FBT's top sector exposures are Health Care, HTEC is more expensive with a Total Expense Ratio (TER) of 0.8%, versus 0.54% for FBT. HTEC is down -5.19% year-to-date (YTD) with - in YTD flows. FBT performs worse with -5.96% YTD performance, and +$1.10B in YTD flows. Run a side-by-side ETF comparison of HTEC and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
HTEC vs FBT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HTEC FBT | -4.76%-5.58% | -5.68%-7.34% | -5.19%-5.96% | +21.07%+15.04% | +18.57%+29.35% | -23.52%+20.07% |
| Flows | HTEC FBT | -+$11M | -+$1.10B | -+$1.10B | -$4M+$1.09B | -$60M+$639M | -$82M+$246M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HTEC FBT | +16.61%+22.00% | +21.87%+24.20% | +19.84%+19.85% | +23.75%+21.81% |
| Max drawdown | HTEC FBT | -11.97%-12.74% | -15.36%-14.81% | -28.61%-19.92% | -56.05%-29.98% |
| Max drawdown duration | HTEC FBT | 48d49d | 99d148d | 546d237d | 1651d1243d |
HTEC | FBT | |
Last sale 3/13/2026 at 1:30 PM | $32.36 | $192.63 |
| Previous close 03/12/2026 | $32.41 | $193.57 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HTEC | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HTEC | FBT | |
|---|---|---|
| Last price | $32.36 | $192.63 |
| 1D performance | -0.15% | -0.49% |
| AuM | $50.42 M | $2.22 B |
| E/R | 0.8% | 0.54% |
HTEC | FBT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | ROBO Global ETFs | First Trust |
| Benchmark | ROBO Global Healthcare Technology and Innovation | NYSE Arca Biotechnology Index |
| N° of holdings | 58 | 28 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 25, 2019 | June 19, 2006 |
| ESG | Yes | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the HTEC and FBT ETFs performed in 2026?
As of March 11, 2026, HTEC is down -5.19% year-to-date (YTD), while FBT has lost -5.96%. That puts HTEC better performer ahead so far this year.
Which ETF is attracting more investor money: HTEC or FBT?
Year-to-date, the HTEC ETF saw - in flows, compared to +$1.10B for FBT.
Which ETF is more volatile: HTEC or FBT?
Over the past year, HTEC had a volatility of 21.87%, while FBT experienced 24.2%.
Which ETF is bigger: HTEC or FBT?
As of March 11, 2026, HTEC holds $50.42 M in assets under management (AUM), while FBT manages $2.22 B.
What sectors do the HTEC and FBT ETFs invest in?
HTEC leans toward sectors like Health Care. Meanwhile, FBT focuses on Health Care.
What are the top holdings of the HTEC ETF and FBT ETF?
HTEC top holdings include MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and GUARDANT HEALTH INC. FBT holds in its top three: MODERNA INC, GILEAD SCIENCES and ALKERMES.
Which ETF is more diversified: HTEC or FBT?
HTEC holds 58 securities with 30.14% of its assets in the top 15. FBT has 30 securities and a top 15 weight of 53.69%.
Biggest potential ETF theme - Innovation
Biotech ETFs – Investing in Health Innovation
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
